| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.5 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |